Brief: TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
29/03/2021 13:16
March 29 (Reuters) - TCR2 Therapeutics Inc TCRR.O :
* TCR² THERAPEUTICS ESTABLISHES COMMERCIAL-SCALE CELL
THERAPY
MANUFACTURING FACILITY
Source text for Eikon: ID:nGNXD1ClT
Further company coverage: TCRR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TCR2 Therapeutics
See all newsBrief: TCR2 Therapeutics Entered Into An Assignment Of Lease Agreement With Astrazeneca
TCR2 Therapeutics falls on bigger-than-expected Q1 loss
Brief: Tcr² Therapeutics Reports Q1 2023 Financial Results And Provides Corporate Update
TCR2 Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
TCR2 Therapeutics Inc expected to post a loss of 68 cents a share - Earnings Preview